Market Cap | 121.82M | P/E | - | EPS this Y | 11.10% | Ern Qtrly Grth | - |
Income | -22.08M | Forward P/E | -8.39 | EPS next Y | 25.00% | 50D Avg Chg | -14.00% |
Sales | 23.75M | PEG | - | EPS past 5Y | - | 200D Avg Chg | -23.00% |
Dividend | N/A | Price/Book | 4.78 | EPS next 5Y | - | 52W High Chg | -45.00% |
Recommedations | 2.20 | Quick Ratio | 1.43 | Shares Outstanding | 84.66M | 52W Low Chg | 6.00% |
Insider Own | 15.65% | ROA | -32.18% | Shares Float | 58.41M | Beta | 1.56 |
Inst Own | 48.27% | ROE | -94.89% | Shares Shorted/Prior | 3.27M/3.23M | Price | 1.51 |
Gross Margin | 59.28% | Profit Margin | -87.38% | Avg. Volume | 325,970 | Target Price | 4.50 |
Oper. Margin | -133.74% | Earnings Date | Nov 7 | Volume | 154,700 | Change | 1.34% |
Stereotaxis, Inc. designs, manufactures, and markets robotic systems, instruments, and information systems for the interventional laboratory in the United States and internationally. Its robotic magnetic navigation (RMN) systems include the Genesis RMN and Niobe systems, which enable physicians to complete complex interventional procedures by providing image-guided delivery of catheters and guidewires through the blood vessels and chambers of the heart to treatment sites. The company provides Odyssey, a real-time information solution to manage, control, record, and share procedures across networks; and Stereotaxis Imaging Model S X-ray system, a single-plane, full-power x-ray system, including c-arm, powered table, motorized boom, and monitors for a robotic interventional operating room. In addition, it offers disposables and other accessories, such as QuikCAS automated catheter advancement disposables for the remote advancement of electrophysiology catheters. Further, the company provides Vdrive, a system that offers navigation and stability for the diagnostic and therapeutic devices designed to improve interventional procedures; and V-Loop, V-Sono, and V-CAS disposable components. It markets its products through direct sales force, distributors, and sales agents. The company has a strategic collaboration with MAGiC catheter for cardiac ablation procedures. Stereotaxis, Inc. was incorporated in 1990 and is based in Saint Louis, Missouri.
Insider Trades | Relationship | Date | Transactions | Cost($) | #Shares | Value($) | #Share Own | SEC Form 4 |
---|---|---|---|---|---|---|---|---|
Isaac Paul J | Director Director | Dec 15 | Buy | 1.72 | 11,060 | 19,023 | 2,739,693 | 12/18/23 |
Isaac Paul J | Director Director | Nov 21 | Buy | 1.52 | 6,018 | 9,147 | 2,725,825 | 11/24/23 |
Isaac Paul J | Director Director | Nov 17 | Buy | 1.55 | 12,000 | 18,600 | 2,719,807 | 11/21/23 |
Isaac Paul J | Director Director | Nov 15 | Buy | 1.48 | 35,000 | 51,800 | 2,707,807 | 11/17/23 |
Isaac Paul J | Director Director | Nov 13 | Buy | 1.45 | 20,000 | 29,000 | 2,672,807 | 11/15/23 |
Isaac Paul J | Director Director | Sep 14 | Buy | 1.64 | 23,168 | 37,996 | 2,652,807 | 09/18/23 |
Isaac Paul J | Director Director | Sep 12 | Buy | 1.68 | 7,505 | 12,608 | 2,629,639 | 09/14/23 |
Isaac Paul J | Director Director | Aug 30 | Buy | 1.71 | 10,000 | 17,100 | 2,622,134 | 09/01/23 |
Isaac Paul J | Director Director | Aug 28 | Buy | 1.71 | 16,050 | 27,446 | 2,612,134 | 08/30/23 |
Isaac Paul J | Director Director | Aug 24 | Buy | 1.75 | 9,000 | 15,750 | 2,596,084 | 08/28/23 |
Isaac Paul J | Director Director | May 25 | Buy | 1.83 | 14,300 | 26,169 | 2,528,583 | 06/01/22 |
Isaac Paul J | Director Director | May 23 | Buy | 1.83 | 14,292 | 26,154 | 2,514,283 | 05/25/22 |
Isaac Paul J | Director Director | May 16 | Buy | 1.82 | 55,025 | 100,146 | 2,456,728 | 05/19/22 |
Isaac Paul J | Director Director | May 12 | Buy | 1.83 | 156,751 | 286,854 | 2,401,703 | 05/16/22 |